Progress Made Towards a Simple, Low-cost CRISPR-based SARS-CoV-2 Diagnostic
Achieved by the researchers in the Department of Biomedical Engineering— a shared department in the schools of Dental Medicine, Medicine, and Engineering—have been working to develop a new, low-cost, CRISPR-based diagnostic platform to detect infectious diseases, including the novel coronavirus (SARS-CoV-2).
Head of the Lab Dr. Chunchun Liu is delivering a Live Webinar with CPD accreditation on the same.
For details: https://www.thetalks.com/webinar/aiod_crispr
Contact: raj@thepharmaceuticaltalks.org
Head of the Lab Dr. Chunchun Liu is delivering a Live Webinar with CPD accreditation on the same.
For details: https://www.thetalks.com/webinar/aiod_crispr
Contact: raj@thepharmaceuticaltalks.org